ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625505 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625505; 2) Community: the network communities that were significantly associated with the response to NSC 625505; 3) Molecule: the relationships between components within communities and NSC 625505; 4) MDR: the compounds that were significantly associated with the NSC 625505.

NSC Compound Enrichment Correlation
NSC 724780 (1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15 0.0123744972338278 0.3201723
NSC 736079 4-[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-6-pyrrolidin-1-yl-1 ,3,5-triazin-2-ylamine 0.0123744972338278 0.43438045
NSC 759322 MEVASTATIN 0.0123744972338278 -0.11298119
NSC 99027 Null 0.0123744972338278 0.22908744
NSC 166588 METHYLUNDECYLPIPERIDINE, TRANS 0.0123744972338279 0.47852205
NSC 350895 Bleomycin A5 0.0123744972338279 -0.16730529
NSC 605440 Isothiazolo[2,3-a]azepine, 5,7-bis(trifluoromethyl)- 2,3-dihydro-, 1,1-dioxide 0.0123744972338279 0.31821649
NSC 625496 Null 0.0123744972338279 0.86002733
NSC 636984 Null 0.0133299224082802 0.41410427
NSC 641283 Null 0.0133299224082802 0.40453399
Total:118  Current:49    [First] [Prev] [Next] [Last]